Velikyan I - Search Results

1

Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors.

Sandström M, Velikyan I, Garske-Román U, Sörensen J, Eriksson B, Granberg D, Lundqvist H, Sundin A, Lubberink M. Sandström M, et al. Among authors: velikyan i. J Nucl Med. 2013 Oct;54(10):1755-9. doi: 10.2967/jnumed.113.120600. Epub 2013 Aug 8. J Nucl Med. 2013. PMID: 23929824 Free article.

2

68Ga-labeled oligonucleotides for in vivo imaging with PET.

Roivainen A, Tolvanen T, Salomäki S, Lendvai G, Velikyan I, Numminen P, Välilä M, Sipilä H, Bergström M, Härkönen P, Lönnberg H, Långström B. Roivainen A, et al. Among authors: velikyan i. J Nucl Med. 2004 Feb;45(2):347-55. J Nucl Med. 2004. PMID: 14960659 Free article.

3

Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.

Velikyan I, Sundberg AL, Lindhe O, Höglund AU, Eriksson O, Werner E, Carlsson J, Bergström M, Långström B, Tolmachev V. Velikyan I, et al. J Nucl Med. 2005 Nov;46(11):1881-8. J Nucl Med. 2005. PMID: 16269603 Free article.

4

Biodistribution of 68Ga-labeled LNA-DNA mixmer antisense oligonucleotides for rat chromogranin-A.

Lendvai G, Velikyan I, Estrada S, Eriksson B, Långström B, Bergström M. Lendvai G, et al. Among authors: velikyan i. Oligonucleotides. 2008 Spring;18(1):33-49. doi: 10.1089/oli.2007.0104. Oligonucleotides. 2008. PMID: 18321161

5

The importance of high specific radioactivity in the performance of 68Ga-labeled peptide.

Velikyan I, Beyer GJ, Bergström-Pettermann E, Johansen P, Bergström M, Långström B. Velikyan I, et al. Nucl Med Biol. 2008 Jul;35(5):529-36. doi: 10.1016/j.nucmedbio.2008.03.002. Nucl Med Biol. 2008. PMID: 18589296

6

Non-hybridization saturable mechanisms play a role in the uptake of (68)Ga-Labeled LNA-DNA mixmer antisense oligonucleotides in rats.

Lendvai G, Monazzam A, Velikyan I, Eriksson B, Josephsson R, Långström B, Bergström M, Estrada S. Lendvai G, et al. Among authors: velikyan i. Oligonucleotides. 2009 Sep;19(3):223-32. doi: 10.1089/oli.2009.0192. Oligonucleotides. 2009. PMID: 19732020

7

A HER2-binding Affibody molecule labelled with 68Ga for PET imaging: direct in vivo comparison with the 111In-labelled analogue.

Tolmachev V, Velikyan I, Sandström M, Orlova A. Tolmachev V, et al. Among authors: velikyan i. Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1356-67. doi: 10.1007/s00259-009-1367-7. Epub 2010 Feb 4. Eur J Nucl Med Mol Imaging. 2010. PMID: 20130858

8

In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours--impact of peptide mass.

Velikyan I, Sundin A, Eriksson B, Lundqvist H, Sörensen J, Bergström M, Långström B. Velikyan I, et al. Nucl Med Biol. 2010 Apr;37(3):265-75. doi: 10.1016/j.nucmedbio.2009.11.008. Epub 2010 Jan 15. Nucl Med Biol. 2010. PMID: 20346866

9

Ventilation distribution studies comparing Technegas and "Gallgas" using 68GaCl3 as the label.

Borges JB, Velikyan I, Långström B, Sörensen J, Ulin J, Maripuu E, Sandström M, Widström C, Hedenstierna G. Borges JB, et al. Among authors: velikyan i. J Nucl Med. 2011 Feb;52(2):206-9. doi: 10.2967/jnumed.110.083881. Epub 2011 Jan 13. J Nucl Med. 2011. PMID: 21233191 Free article.

10

Improved tumor-to-organ ratios of a novel 67Ga-human epidermal growth factor radionuclide conjugate with preadministered antiepidermal growth factor receptor affibody molecules.

Sandström K, Haylock AK, Velikyan I, Spiegelberg D, Kareem H, Tolmachev V, Lundqvist H, Nestor M. Sandström K, et al. Among authors: velikyan i. Cancer Biother Radiopharm. 2011 Oct;26(5):593-601. doi: 10.1089/cbr.2011.0981. Epub 2011 Aug 11. Cancer Biother Radiopharm. 2011. PMID: 21834651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page